Breaking News
Sort by:
Top Post
Blood Vessel Breakthrough Major Step Towards Alzheimers Treatment
A breakthrough in our understanding of Alzheimer’s disease has revealed changes to blood vessels in […]
Idoven Raises $19.8 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI
Idoven, a pioneering health tech company advancing early detection and precision medicine of cardiovascular disease, […]
New AI Tool Is Better at Spotting Heart Failure Than Current Tests
A new artificial intelligence (AI) tool can help diagnose acute heart failure more accurately than […]
MEDICALGORITHMICS Secured FDA Approval for Qpatch Wearable
Qpatch is a state-of-the-art wearable device for measuring individual ECG signal to obtain accurate cardiac […]
Vironix Health has Partnered with The Landon Pediatric Foundation to Bring AI-Healthcare Technology to Southern California
Digital Health Company Vironix Health has teamed up with LPF to increase access to affordable healthcare and […]
Obesity Linked to Damaging Changes in Failing Hearts
Obesity is linked to changes in the structure and pumping action of the heart before […]
Novartis UK Launches New Heart Failure Insights Tool to Address Health Inequalities in England
Novartis UK has today announced the launch of a new heart failure Health Inequalities Insights […]
MediCardia Health Inc. Integrates Optimize EP C-aRM to Develop First of it's Kind, Comprehensive Connected Cardiac Care Platform
MediCardia Health Inc., a pioneer in global digital health, announced today that the Company has […]
Spending Less Time Watching TV Could Cut Coronary Heart Disease Risk
Watching too much TV is associated with an increased risk of coronary heart disease regardless […]
inHEART Receives FDA Clearance for Novel 3D Cardiac Modeling Solution
inHEART, a privately-held medical device company delivering the world’s most sophisticated digital twin of the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more